Publication | Closed Access
Novel β-carboline–quinazolinone hybrid as an inhibitor of Leishmania donovani trypanothione reductase: Synthesis, molecular docking and bioevaluation
38
Citations
27
References
2014
Year
Drug TargetAntiparasitic AgentPossible Binding SitesChemical BiologyPharmaceutical ChemistryVisceral LeishmaniasisMolecular PharmacologyMedicinal ChemistryNovel β-Carboline–quinazolinone HybridBiochemistryAfrican TrypanosomiasisMedicineParasitic ProtozoaPharmacologyMolecular ModelingNatural SciencesNovel β-Carboline–quinazolinone HybridsMolecular DockingDrug DiscoveryTrypanothione Reductase
Novel β-carboline–quinazolinone hybrids are able to inhibit <italic>Leishmania donovani</italic> TR (LdTR). Molecular docking studies to investigate possible binding sites were performed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1